Amedisys [AMED] vs HCA Healthcare [HCA] Detailed Stock Comparison

Amedisys Inc.

NASDAQ
Loading...

HCA Healthcare Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Amedisys Inc. wins in 7 metrics, HCA Healthcare Inc. wins in 13 metrics, with 0 ties. HCA Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amedisys Inc. HCA Healthcare Inc. Better
P/E Ratio (TTM) 39.30 16.86 HCA Healthcare Inc.
Price-to-Book Ratio 2.69 -38.44 Amedisys Inc.
Debt-to-Equity Ratio 35.34 -17.57 Amedisys Inc.
PEG Ratio -2.78 0.37 HCA Healthcare Inc.
EV/EBITDA 13.74 10.08 HCA Healthcare Inc.
Profit Margin (TTM) 3.56% 8.97% HCA Healthcare Inc.
Operating Margin (TTM) 11.70% 16.29% HCA Healthcare Inc.
EBITDA Margin (TTM) 11.70% 16.29% HCA Healthcare Inc.
Return on Equity 6.67% -244.82% Amedisys Inc.
Return on Assets (TTM) 6.52% 12.44% HCA Healthcare Inc.
Free Cash Flow (TTM) $214.29M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return 2.68% 4.31% HCA Healthcare Inc.
Price-to-Sales Ratio (TTM) 1.38 1.39 Amedisys Inc.
Enterprise Value $3.48B $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 1.45 2.07 Amedisys Inc.
Gross Profit Margin (TTM) 43.96% 41.90% Amedisys Inc.
Revenue per Share (TTM) $73 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $2.57 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 0.90 1.37 Amedisys Inc.
Short % of Float 9.90% 2.45% HCA Healthcare Inc.

Amedisys Inc. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

AMED
HCA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amedisys Inc.0.00%0.05%3.57%7.76%10.13%10.13%
HCA Healthcare Inc.0.72%7.93%-7.81%-25.75%-18.24%-17.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amedisys Inc.2.68%-14.45%-58.43%149.36%328.29%215.59%
HCA Healthcare Inc.4.31%33.47%92.28%400.04%1,019.34%1,144.15%

Performance & Financial Health Analysis: Amedisys Inc. vs HCA Healthcare Inc.

MetricAMEDHCA
Market Information
Market Cap i$3.32B$106.00B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i1,027,642795,641
90 Day Avg. Volume i618,767974,074
Last Close$100.99$389.97
52 Week Range$82.15 - $101.02$330.00 - $556.52
% from 52W High-0.03%-29.93%
All-Time High$325.12 (Jan 25, 2021)$556.52 (Mar 12, 2026)
% from All-Time High-68.94%-29.93%
Growth Metrics
Quarterly Revenue Growth0.05%0.07%
Quarterly Earnings Growth-0.13%0.31%
Financial Health
Profit Margin (TTM) i0.04%0.09%
Operating Margin (TTM) i0.12%0.16%
Return on Equity (TTM) i0.07%-2.45%
Debt to Equity (MRQ) i35.34-17.57
Cash & Liquidity
Book Value per Share (MRQ)$37.48$-26.83
Cash per Share (MRQ)$10.26$5.11
Operating Cash Flow (TTM) i$239.42M$12.64B
Levered Free Cash Flow (TTM) i$300.69M$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: Amedisys Inc. vs HCA Healthcare Inc.

MetricAMED (Aug 31, 2025)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i39.3016.86
Forward P/E i19.7614.13
PEG Ratio i-2.780.37
Price to Sales (TTM) i1.381.39
Price to Book (MRQ) i2.69-38.44
Market Capitalization
Market Capitalization i$3.32B$106.00B
Enterprise Value i$3.48B$156.18B
Enterprise Value Metrics
Enterprise to Revenue i1.452.07
Enterprise to EBITDA i13.7410.08
Risk & Other Metrics
Beta i0.901.37
Book Value per Share (MRQ) i$37.48$-26.83

Financial Statements Comparison: Amedisys Inc. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMED (2024)HCA (2025)
Revenue/Sales i2.35B75.60B
Cost of Goods Sold i1.33B44.23B
COGS % of Revenue i56.7%58.5%
Gross Profit i1.02B31.37B
Gross Margin i43.3%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i209.57M11.97B
Operating Margin i8.9%15.8%
EBITDA i292.47M15.57B
EBITDA Margin i12.5%20.6%
Pre-Tax Income i86.22M9.83B
Pre-Tax Income % of Revenue i3.7%13.0%
Income Tax i48.05M2.05B
Income Tax % of Revenue i2.0%2.7%
Net Income (Profit) i38.16M7.78B
Profit Margin i1.6%10.3%

Balance Sheet & Liquidity Metrics

MetricAMED (2024)HCA (2025)
Cash & Equivalents i303.24M1.04B
Total Current Assets i632.08M15.78B
Total Current Assets % of Revenue i26.9%20.9%
Total Current Liabilities i514.39M16.35B
Total Current Liabilities % of Revenue i21.9%21.6%
Long-Term Debt i395.42M43.46B
Long-Term Debt % of Revenue i16.8%57.5%
Total Shareholders Equity i1.18B-2.77B
Retained Earnings i791.16M-5.72B
Retained Earnings % of Revenue i33.7%-7.6%
Property, Plant & Equipment i167.80M39.12B

Cash Flow Statement Comparison

MetricAMED (2024)HCA (2025)
Operating Cash Flow i144.50M12.01B
Operating Cash Flow % of Revenue i6.2%15.9%
Capital Expenditures i-6.55M-4.94B
Free Cash Flow i214.29M7.69B
FCF Margin i9.1%10.2%
Debt Repayment i0-7.39B
Common Stock Repurchase i-6.15M-10.07B

Short Interest & Institutional Ownership Analysis

MetricAMEDHCA
Shares Short i3.20M3.63M
Short Ratio i6.843.37
Short % of Float i9.90%2.45%
Shares Outstanding i32.78M224.61M
Float Shares i32.24M151.19M
% Held by Insiders i1.95%16.16%
% Held by Institutions i96.37%78.70%
% Held by Public i1.68%5.14%

Dividend Analysis & Yield Comparison: Amedisys Inc. vs HCA Healthcare Inc.

MetricAMEDHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026